Bristol Myers Squibb BMY
NYSE BMY
$61.38 +2.55 (+4.33%)
As of: Oct 20, 2026 · 11:56 AM EDT

Bristol Myers Squibb (BMY) Gross Profit (2009 - 2026)

Updated

Bristol Myers Squibb's Gross Profit came in at $9.25 billion for Q2 2026, up 3.9% from $8.9 billion a year earlier and up 14.6% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Gross Profit (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Bristol Myers Squibb reported Gross Profit of $34.51 billion, up 2.9% year-over-year; for FY2025, it came in at $34.26 billion, down 0.2% from FY2024.

  • Gross Profit carries a five-year compound annual growth rate of 2.2% (FY2020 to FY2025).
  • Going back by year, Gross Profit was $34.33 billion in FY2024 (+0.1%), $34.31 billion in FY2023 (-4.7%), $36.02 billion in FY2022 (-1.2%) and $36.45 billion in FY2021 (+18.5%).
  • The Q2 2026 figure represents the highest quarterly Gross Profit since Q4 2021.
  • Year-over-year, Gross Profit increased in three of the last eight quarters, with an average decline of 0.6%.
  • The fastest year-over-year change in Gross Profit over five years came in Q4 2021 (growth of 18.0%), and the weakest in Q4 2024 (a decline of 13.8%).
  • Business Quant data shows BMY's Gross Profit at $8.07 billion (Q1 2026), $8.41 billion (Q4 2025) and $8.79 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Bristol Myers Squibb Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=BMY&period=max&api_key=YOUR_API_KEY